NeuroBo Pharmaceuticals - Stock Price History | MTVA
Historical daily share price chart and data for NeuroBo Pharmaceuticals since adjusted for splits and dividends. The latest closing stock price for NeuroBo Pharmaceuticals as of December 31, 1969 is 0.00.
- The all-time high NeuroBo Pharmaceuticals stock closing price was 0.00 on December 31, 1969.
- The NeuroBo Pharmaceuticals 52-week high stock price is 0.00, which is NAN% above the current share price.
- The NeuroBo Pharmaceuticals 52-week low stock price is 0.00, which is NAN% below the current share price.
- The average NeuroBo Pharmaceuticals stock price for the last 52 weeks is NaN.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| NeuroBo Pharmaceuticals Historical Annual Stock Price Data |
| Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.022B |
$0.000B |
|
NeuroBo Pharmaceuticals Inc. is a biopharmaceutical company. It is focused on novel treatments for neurodegenerative diseases. The company's novel lead candidate NB-01 is a drug candidate for diabetic neuropathic pain. NB-02 focuses on the treatment of neurodegenerative diseases. NeuroBo Pharmaceuticals Inc., formerly known as Gemphire Therapeutics Inc., is based in Northville, United States.
|
